Karen Pendergrass

Karen Pendergrass, Standards Team

About

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.

Recent Posts

2026-07-05

Bifidobacteria support optimal infant vaccine responses

In 191 infants, direct neonatal antibiotics were linked to lower antibody titres against pneumococcal, Hib and diphtheria vaccines and to reduced gut Bifidobacterium at the time of vaccination. In mice, Bifidobacterium species or a neonatal probiotic restored pneumococcal vaccine responses.

2026-07-05

Alterations in the human oral and gut microbiomes and lipidomics in COVID-19

COVID-19 patients showed reduced oral and gut microbial diversity, with fewer butyric-acid-producing and more lipopolysaccharide-producing bacteria. Classifiers built on 8 oral and 7 fecal microbial markers diagnosed COVID-19 with area-under-curve values above 0.87, and diagnosed antibody-positive suspected cases.